BioSpace News Archive

C4XD and Garvan Institute of Medical Research report successful patient stratification approach using C4XD’s new precision medicine platform PatientSeek

C4X Discovery Holdings plc, a pioneering Drug Discovery company, announces the launch of a precision medicine platform, PatientSeek, following insights from a successful research collaboration with Garvan Institute of Medical Research.

February 22, 2023

·

6 min read

Drug Development

LinKinVax Welcomes Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate

LinKinVax, a clinical-stage biotechnology company, welcomes the interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine and conducted by the sponsor INSERM-ANRS and the Vaccine Research Institute.

February 22, 2023

·

5 min read

NRG Therapeutics Awarded Second $500K Grant from The Michael J. Fox Foundation to Further Progress Parkinson’s Programme

NRG Therapeutics, Ltd. is pleased to announce that it has been awarded a second $500,000 grant from The Michael J. Fox Foundation for Parkinson’s Research, to support its lead drug discovery programme and the development of a novel treatment for Parkinson’s.

February 22, 2023

·

3 min read

Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases

Resalis Therapeutics announced its completion of the seed financing round of €10 million to establish a non-coding RNA -based therapeutic approach for the treatment of metabolic diseases.

February 22, 2023

·

4 min read

BioMidwest

Exact Sciences to participate in March investor conferences - February 22, 2023

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

February 22, 2023

·

1 min read

Sinovac Amends Shareholder Rights Plan - February 22, 2023

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its board of directors has amended its shareholder rights plan.

February 22, 2023

·

2 min read

Business

Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates

Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today reported business highlights and financial results for the fourth quarter and full year 2022.

February 22, 2023

·

10 min read

Affimed to Participate in Fireside Chat at the H.C. Wainwright Cell Therapy Virtual Conference

Affimed N.V. announced today its Chief Executive Officer, Dr. Adi Hoess, will participate in a fireside chat at the H.C. Wainwright Cell Therapy Conference on Tuesday, February 28, 2023, at 8:30 a.m. EST / 14:30 CET.

February 22, 2023

·

1 min read

Policy

Teleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)

Teleflex Incorporated, a leading global provider of medical technologies, announced key milestones in the release of two new catheters: the U.S. Food and Drug Administration 510 clearance of the Triumph™ Catheter, and the first clinical use of GuideLiner® Coast™ Catheter.

February 22, 2023

·

4 min read

Business

BiomX Announces $7.5 Million Private Placement

BiomX Inc. today announced that it has entered into a securities purchase agreement (“SPA”) with a select group of institutional and individual investors.

February 22, 2023

·

4 min read